Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Proliferation of smooth muscle cells (SMCs) represents an important event in vascular lesion formation. Despite the common belief that growth factors contribute to the development of the atherosclerotic plaque, until now there has been no direct evidence for a role of mitogens in the development of arterial lesions. Balloon catheter injury of the rat carotid artery is accompanied by death of medial SMCs and is typically followed by proliferation of SMCs with subsequent formation of an intimal lesion. Our hypothesis is that injury causes mitogens to be released from dead cells, which then stimulate cell proliferation. One such mitogen that may be important in this process is basic fibroblast growth factor (bFGF), which can be detected immunocytochemically in SMCs and endothelial cells of adult rat carotid arteries. Systemic injection of a neutralizing antibody against bFGF prior to balloon catheterization significantly decreased the induced SMC proliferation by approximately 80%. The intimal lesion that developed within 8 days after injury, however, was not significantly reduced. The results of this study support the concept that endogenous bFGF is the major mitogen controlling the growth of vascular smooth muscle cells following injury. These data may have implications for the observed failure of endarterectomy and angioplasty procedures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
Self-citationRecent developments in the cell biology of basic fibroblast growth factor.
Rifkin, D. B., & Moscatelli, D. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.1.1 · Cited by 1,021
Saksela, O., & Rifkin, D. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.767 · Cited by 539
Cell proliferation in human coronary arteries.
Gordon, D., Reidy, M. A., Benditt, E. P., & Schwartz, S. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4600 · Cited by 532
Self-citationGonzalez, A. M., Buscaglia, M., Ong, M., & Baird, A. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.753 · Cited by 527
Role of basic fibroblast growth factor in vascular lesion formation.
Lindner, V, Lappi, D. A., Baird, A., Majack, R. A., & Reidy, M. A. (1991) · Circulation Research · doi:10.1161/01.res.68.1.106 · Cited by 517
Self-citationPDGF ligand and receptor gene expression during repair of arterial injury.
Majesky, M. W., Reidy, M. A., Bowen-Pope, D. F., Hart, C. E., Wilcox, J. N., & Schwartz, S. M. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.5.2149 · Cited by 430
Self-citationBouche, G., Gas, N., Prats, H., Baldin, V, Tauber, J. P., Teissié, J., & Amalric, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6770 · Cited by 426
Fingerle, J., Johnson, R., Clowes, A. W., Majesky, M. W., & Reidy, M. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8412 · Cited by 414
Self-citation
Cited by
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
The Emerging Concept of Vascular Remodeling
Epstein, F. H., Gibbons, G. H., & Dzau, V. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405193302008 · Cited by 1,575
Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L. Q., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117018 · Cited by 1,036
The Intima: Soil for Atherosclerosis and Restenosis
Schwartz, S. M., deBlois, D., & O’Brien, E. R. M. (1995) · Circulation Research · doi:10.1161/01.res.77.3.445 · Cited by 971
Bergan, J. J., Schmid-Schönbein, G. W., Smith, P. D. C., Nicolaides, A. N., Boisseau, M. R., & Eklof, B. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055289 · Cited by 933
Arterial Remodeling After Coronary Angioplasty: A Serial Intravascular Ultrasound Study
Mintz, G. S., Popma, J. J., Pichard, A. D., Kent, K. M., Satler, L. F., Chiu Wong, S., Hong, M. K., Kovach, J. A., & Leon, M. B. (1996) · Circulation · doi:10.1161/01.cir.94.1.35 · Cited by 889
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
Dzau, V. J., Braun-Dullaeus, R. C., & Sedding, D. G. (2002) · Nature Medicine · doi:10.1038/nm1102-1249 · Cited by 831
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
Simons, M., Edelman, E. R., DeKeyser, J.-L., Langer, R., & Rosenberg, R. D. (1992) · Nature · doi:10.1038/359067a0 · Cited by 731
Jawien, A., Bowen-Pope, D. F., Lindner, V, Schwartz, S. M., & Clowes, A. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115613 · Cited by 674
Self-citationEtiology and pathogenesis of uterine leiomyomas: a review.
Flake, G. P., Andersen, J., & Dixon, D. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5787 · Cited by 583
Asahara, T., Bauters, C., Pastore, C., Kearney, M., Rossow, S., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1995) · Circulation · doi:10.1161/01.cir.91.11.2793 · Cited by 544
(1992) · Circulation · doi:10.1161/01.cir.86.1.100 · Cited by 539
Salvage of Infarcted Myocardium by Angiogenic Action of Basic Fibroblast Growth Factor
Yanagisawa-Miwa, A., Uchida, Y., Nakamura, F., Tomaru, T., Kido, H., Kamijo, T., Sugimoto, T., Kaji, K., Utsuyama, M., Kurashima, C., et al. (1992) · Science · doi:10.1126/science.1382313 · Cited by 517
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Law, R. E., Meehan, W. P., Xi, X. P., Graf, K., Wuthrich, D. A., Coats, W., Faxon, D., & Hsueh, W. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118991 · Cited by 476
Morishita, R., Gibbons, G. H., Ellison, K. E., Nakajima, M., Zhang, L., Kaneda, Y., Ogihara, T., & Dzau, V. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8474 · Cited by 458
Yablonka-Reuveni, Z., & Rivera, A. J. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1226 · Cited by 455
Pathobiology of intimal hyperplasia
Davies, M. G., & Hagen, P.-O. (1994) · Journal of British Surgery · doi:10.1002/bjs.1800810904 · Cited by 413
Migration of smooth muscle and endothelial cells. Critical events in restenosis.
Casscells, W. (1992) · Circulation · doi:10.1161/01.cir.86.3.723 · Cited by 399
Redox Control of the Cell Cycle in Health and Disease
Sarsour, E. H., Kumar, M. G., Chaudhuri, L., Kalen, A. L., & Goswami, P. C. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2513 · Cited by 381
Fibroblast growth factor 2 control of vascular tone
Zhou, M., Sutliff, R. L., Paul, R. J., Lorenz, J. N., Hoying, J. B., Haudenschild, C. C., Yin, M., Coffin, J. D., Kong, L., Kranias, E. G., et al. (1998) · Nature Medicine · doi:10.1038/nm0298-201 · Cited by 380
Mouse model of arterial injury.
Lindner, V, Fingerle, J., & Reidy, M. A. (1993) · Circulation Research · doi:10.1161/01.res.73.5.792 · Cited by 363
Self-citationNewby, A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00286-7 · Cited by 362
Higashiyama, S., Abraham, J., & Klagsbrun, M. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.4.933 · Cited by 362
Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts
Roy-Chaudhury, P., Kelly, B. S., Miller, M. A., Reaves, A., Armstrong, J., Nanayakkara, N., & Heffelfinger, S. C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00750.x · Cited by 351
Potential mechanisms promoting restenosis in diabetic patients
Aronson, D., Bloomgarden, Z., & Rayfield, E. J. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00496-3 · Cited by 327
Lafont, A., Guzman, L. A., Whitlow, P. L., Goormastic, M., Cornhill, J. F., & Chisolm, G. M. (1995) · Circulation Research · doi:10.1161/01.res.76.6.996 · Cited by 310
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.
Wolf, Y. G., Rasmussen, L. M., & Ruoslahti, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117070 · Cited by 304
Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.
Harada, K., Grossman, W., Friedman, M., Edelman, E. R., Prasad, P. V., Keighley, C. S., Manning, W. J., Sellke, F. W., & Simons, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117378 · Cited by 304
Blotnick, S., Peoples, G. E., Freeman, M. R., Eberlein, T. J., & Klagsbrun, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.2890 · Cited by 303
Bendeck, M. P., Irvin, C., & Reidy, M. A. (1996) · Circulation Research · doi:10.1161/01.res.78.1.38 · Cited by 297
Self-citationSustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury.
Tanaka, H., Sukhova, G. K., Swanson, S. J., Clinton, S. K., Ganz, P., Cybulsky, M. I., & Libby, P. (1993) · Circulation · doi:10.1161/01.cir.88.4.1788 · Cited by 265
Edelman, E. R., Nugent, M. A., Smith, L. T., & Karnovsky, M. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115607 · Cited by 245
lncRNA/MicroRNA interactions in the vasculature
Ballantyne, M., McDonald, R., & Baker, A. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.355 · Cited by 242
“In contrast, pretreatment with antibodies to bFGF inhibited early medial proliferation, but not later intimal migration and proliferation of VSMC.14 Furthermore, systemic infusion of bFGF increased intimal hyperplasia following balloon injury in rats.15 However, infusion of PDGF or bFGF did not induce intimal lesion f…”
BackgroundIntimal Hyperplasia in Vascular Grafts
Lemson, M. S., Tordoir, J. H. M., Daemen, M. J. A. P., & Kitslaar, P. J. E. H. M. (2000) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.1999.1040 · Cited by 227
The activated mesangial cell: a glomerular "myofibroblast"?
Johnson, R. J., Floege, J., Yoshimura, A., Iida, H., Couser, W. G., & Alpers, C. E. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v210s190 · Cited by 223
Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era
Stewart, E. (1996) · Human Reproduction Update · doi:10.1093/humupd/2.4.295 · Cited by 210
“…in vivo (Presta, 1988). bFGF has also been shown to be the major mitogen causing the proliferation of vascular smooth-muscle cells after injury (Lindner and Reidy, 1991). bFGF has been detected by polymerase chain reaction in human endometrium throughout the menstrual cycle and shown by…”
BackgroundFlugelman, M. Y., Virmani, R., Correa, R., Yu, Z. X., Farb, A., Leon, M. B., Elami, A., Fu, Y. M., Casscells, W., & Epstein, S. E. (1993) · Circulation · doi:10.1161/01.cir.88.6.2493 · Cited by 162
The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy
Tal, R., & Segars, J. H. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt042 · Cited by 159
“…mechanisms, including the induction of endothelial cell proliferation, chemotaxis and the production of matrix-remodeling enzymes such as collagenase and plasminogen activator (Presta, 1988). bFGF also causes proliferation of vascular SMCs in response to vascular injury (Lindner and Reidy, 1991).”
BackgroundLindner, V, Olson, N. E., Clowes, A. W., & Reidy, M. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116085 · Cited by 159
Self-citationLord, M. S., Chuang, C. Y., Melrose, J., Davies, M. J., Iozzo, R. V., & Whitelock, J. M. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.01.016 · Cited by 130
JANUS under stress—Role of JAK/STAT signaling pathway in vascular diseases
Grote, K., Luchtefeld, M., & Schieffer, B. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.08.021 · Cited by 128
“, 1990) and RAS inhibition prevent the injury-induced neointima formation (Lindner and Reidy, 1991), Ang II seems to be mainly contributed to neointima formation.”
BackgroundHlawaty, H., Suffee, N., Sutton, A., Oudar, O., Haddad, O., Ollivier, V., Laguillier-Morizot, C., Gattegno, L., Letourneur, D., & Charnaux, N. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.09.021 · Cited by 62
Metadata
- Authors
- Lindner, V, & Reidy, M. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1991-05
- Volume
- 88
- Issue
- 9
- Pages
- 3739-3743
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2013012232
- Cited by
- 719
- References
- 22
- FWCI
- 18.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.